Ispecimen INC DEF 14A proxy statements

iSpecimen Inc. filed an amendment to its proxy statement to clarify the quorum requirement for its 2025 Annual Meeting, reducing it to 34% of voting power.

iSpecimen Inc. announces its 2025 Annual Meeting of Stockholders to vote on director elections, auditor ratification, and a new 2025 Stock Incentive Plan.

iSpecimen Inc. calls a special meeting to vote on a reverse stock split, authorized share increase, and new financing mechanisms to maintain Nasdaq listing and fund a digital asset treasury.

iSpecimen Inc. is asking stockholders to approve a reverse stock split at its upcoming annual meeting to maintain compliance with Nasdaq's minimum bid price requirement.